Overview
The Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW study is the first to address this topic.
Eligibility
Inclusion Criteria:
- patients with T1D
- type 1 diabetes for ≥1 years
- ≥ 18 years old
- written informed consent prior to starting study related activity
Exclusion Criteria:
- severe noncompliance
- lactation, pregnancy, intending to become pregnant during study
- use of medication with effects on carbohydrate metabolism